Free Trial
NASDAQ:CAPS

Capstone (CAPS) Stock Price, News & Analysis

$1.82 -0.10 (-5.21%)
As of 03:59 PM Eastern

About Capstone Stock (NASDAQ:CAPS)

Key Stats

Today's Range
$1.65
$1.94
50-Day Range
N/A
52-Week Range
$1.65
$16.18
Volume
65,577 shs
Average Volume
678,986 shs
Market Capitalization
$287,560.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.

Remove Ads
Receive CAPS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Capstone and its competitors with MarketBeat's FREE daily newsletter.

CAPS Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

CAPS Stock Analysis - Frequently Asked Questions

Capstone's stock was trading at $2.40 at the beginning of the year. Since then, CAPS stock has decreased by 24.2% and is now trading at $1.82.
View the best growth stocks for 2025 here
.

Capstone (CAPS) raised $5 million in an IPO on Thursday, March 6th 2025. The company issued 1,250,000 shares at $4.00 per share.

Capstone's quiet period expires on Tuesday, April 15th. Capstone had issued 1,250,000 shares in its initial public offering on March 6th. The total size of the offering was $5,000,000 based on an initial share price of $4.00. During Capstone's quiet period, insiders and any underwriters that worked on the IPO are prevented from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the end of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

Shares of CAPS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CAPS
Web
N/A
Fax
N/A
Employees
38
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$44.05 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$300,200.00
Optionable
N/A
Beta
-0.78
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (NASDAQ:CAPS) was last updated on 4/7/2025 by MarketBeat.com Staff
From Our Partners